IN2015DN01119A - - Google Patents

Info

Publication number
IN2015DN01119A
IN2015DN01119A IN1119DEN2015A IN2015DN01119A IN 2015DN01119 A IN2015DN01119 A IN 2015DN01119A IN 1119DEN2015 A IN1119DEN2015 A IN 1119DEN2015A IN 2015DN01119 A IN2015DN01119 A IN 2015DN01119A
Authority
IN
India
Prior art keywords
compounds
disclosed
methods
intermediates
synthesis
Prior art date
Application number
Other languages
English (en)
Inventor
Ende Christopher William Am
Michael Eric Green
Douglas Scott Johnson
Gregory Wayne Kauffman
Christopher John Odonnell
Nandini Chaturbhai Patel
Martin Youngjin Pettersson
Antonia Friederike Stepan
Cory Michael Stiff
Chakrapani Subramanyam
Tuan Phong Tran
Patrick Robert Verhoest
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IN2015DN01119A publication Critical patent/IN2015DN01119A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1119DEN2015 2012-09-21 2013-09-06 IN2015DN01119A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261703969P 2012-09-21 2012-09-21
PCT/IB2013/058347 WO2014045156A1 (fr) 2012-09-21 2013-09-06 Nouvelles pyridinones bicycliques

Publications (1)

Publication Number Publication Date
IN2015DN01119A true IN2015DN01119A (fr) 2015-06-26

Family

ID=49585452

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1119DEN2015 IN2015DN01119A (fr) 2012-09-21 2013-09-06

Country Status (47)

Country Link
US (3) US8916564B2 (fr)
EP (1) EP2897956B1 (fr)
JP (1) JP5844018B2 (fr)
KR (1) KR101725696B1 (fr)
CN (1) CN104662021B (fr)
AP (1) AP2015008277A0 (fr)
AR (1) AR092628A1 (fr)
AU (1) AU2013319845B2 (fr)
BR (1) BR112015006436A2 (fr)
CA (1) CA2882386C (fr)
CL (1) CL2015000717A1 (fr)
CR (1) CR20150053A (fr)
CU (1) CU20150021A7 (fr)
CY (1) CY1118662T1 (fr)
DK (1) DK2897956T3 (fr)
DO (1) DOP2015000069A (fr)
EA (1) EA026668B1 (fr)
EC (1) ECSP15015594A (fr)
ES (1) ES2609987T3 (fr)
GE (1) GEP201706659B (fr)
GT (1) GT201500069A (fr)
HK (1) HK1206013A1 (fr)
HR (1) HRP20161558T1 (fr)
HU (1) HUE031248T2 (fr)
IL (1) IL237163A (fr)
IN (1) IN2015DN01119A (fr)
LT (1) LT2897956T (fr)
MA (1) MA37886B1 (fr)
MD (1) MD4583B1 (fr)
ME (1) ME02571B (fr)
MX (1) MX360599B (fr)
MY (1) MY181891A (fr)
NI (1) NI201500038A (fr)
NZ (1) NZ704863A (fr)
PE (1) PE20150686A1 (fr)
PH (1) PH12015500376A1 (fr)
PL (1) PL2897956T3 (fr)
PT (1) PT2897956T (fr)
RS (1) RS55426B1 (fr)
SG (1) SG11201501074WA (fr)
SI (1) SI2897956T1 (fr)
TN (1) TN2015000084A1 (fr)
TW (1) TWI500616B (fr)
UA (1) UA110688C2 (fr)
UY (1) UY35039A (fr)
WO (1) WO2014045156A1 (fr)
ZA (1) ZA201501195B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
CA2889249C (fr) 2012-12-20 2021-02-16 Francois Paul Bischoff Derives tricycliques 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione utilises comme modulateurs de la gamma secretase
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
WO2015049616A1 (fr) * 2013-10-04 2015-04-09 Pfizer Inc. Nouvelles pyridinones bicycliques utilisées comme modulateurs de gamma-sécrétase
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
EA031419B1 (ru) * 2014-04-01 2018-12-28 Пфайзер Инк. ХРОМЕН И 1,1a,2,7b-ТЕТРАГИДРОЦИКЛОПРОПА[c]ХРОМЕН ПИРИДОПИРАЗИНДИОНЫ В КАЧЕСТВЕ МОДУЛЯТОРА ГАММА-СЕКРЕТАЗЫ
BR112017015693A2 (pt) * 2015-02-03 2018-03-20 Pfizer ciclopropabenzofuranil piridopirazinadionas
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
WO2017216279A1 (fr) 2016-06-16 2017-12-21 F. Hoffmann-La Roche Ag Modulateurs des récepteurs des œstrogènes hétéroaryles et leurs utilisations
AU2017376109A1 (en) 2016-12-16 2019-07-11 Pipeline Therapeutics, Inc. Methods of treating cochlear synaptopathy
EP3860562A1 (fr) 2018-10-02 2021-08-11 Frequency Therapeutics, Inc. Compositions pharmaceutiques comprenant des agents thérapeutiques otiques et procédés associés
AU2020271067A1 (en) 2019-04-08 2021-11-25 Frequency Therapeutics, Inc. Combination of CHIR99021 and valproic acid for treating hearing loss
CR20220316A (es) 2019-12-06 2022-10-07 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio
CN113402490B (zh) * 2021-03-29 2023-01-03 白银京宇新药业有限公司 一种1，2，6，7-四氢-8H-茚并[5，4-b]呋喃-8-酮的制备方法
AR126073A1 (es) 2021-06-04 2023-09-06 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio
CN114034792A (zh) * 2021-11-09 2022-02-11 山东新华制药股份有限公司 检测氯酮含量的液相色谱分析方法

Family Cites Families (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419788A (en) 1972-08-02 1975-12-31 Pfizer Herbicidal method using 2-trifuluromethyl-4-quinolinols
WO1992000075A1 (fr) 1990-06-29 1992-01-09 Pfizer Inc. Derives de pyridopyrazine utilises dans le traitement de l'abus et de la dependance de substances
EP0585913B1 (fr) 1992-09-04 1997-12-29 Takeda Chemical Industries, Ltd. Composés hétérocycliques condensés, leur production et usage
EP1308461A3 (fr) 1993-01-25 2004-02-11 Takeda Chemical Industries, Ltd. Anticorps contre des bèta-amyloides ou leurs dérivés, et leurs utilisations
ATE242243T1 (de) 1995-03-24 2003-06-15 Takeda Chemical Industries Ltd Zyklische verbindungen, ihre herstellung und ihre verwendung als tachykininrezeptorantagonisten
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
US8173127B2 (en) 1997-04-09 2012-05-08 Intellect Neurosciences, Inc. Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
EP0994728B1 (fr) 1997-04-09 2008-07-30 Intellect Neurosciences, Inc. Anticorps recombines specifiques contre les terminaisons beta-amyloide, codage par molecule d'adn, et leurs procedes d'utilisation
GB9722520D0 (en) 1997-10-24 1997-12-24 Pfizer Ltd Compounds
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6905686B1 (en) 1997-12-02 2005-06-14 Neuralab Limited Active immunization for treatment of alzheimer's disease
CA2322156A1 (fr) 1998-03-03 1999-09-10 Ppg Industries Ohio, Inc. Brins de fibres de verre impregnees et produits comportant de tels brins
US20020132817A1 (en) 1998-03-19 2002-09-19 Hideaki Natsugari Heterocyclic compounds, their production and use
CA2352612A1 (fr) 1998-11-27 2000-06-08 Hideo Fukui Medicaments
PL218883B1 (pl) 2000-02-24 2015-02-27 Lilly Co Eli Kompozycja farmaceutyczna zawierająca przeciwciało do zastosowania w leczeniu klinicznej lub przedklinicznej choroby Alzheimera
DE10045112A1 (de) 2000-09-11 2002-03-21 Merck Patent Gmbh Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
CA2427661C (fr) 2000-11-03 2013-05-28 Proteotech, Inc. Procedes d'isolement de composes inhibiteurs d'amyloide, et utilisation de composes utilises a partir d'uncaria tomentosa et de plantes parentes
WO2003016466A2 (fr) 2001-08-17 2003-02-27 Eli Lilly And Company Anticorps anti-$g(a)$g(b)
US20030195205A1 (en) 2001-11-02 2003-10-16 Pfizer Inc. PDE9 inhibitors for treating cardiovascular disorders
DE10238724A1 (de) 2002-08-23 2004-03-04 Bayer Ag Alkyl-substituierte Pyrazolpyrimidine
DE10238723A1 (de) 2002-08-23 2004-03-11 Bayer Ag Phenyl-substituierte Pyrazolyprimidine
US7517532B2 (en) 2002-09-11 2009-04-14 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
CA2501799C (fr) 2002-10-09 2008-06-17 Pfizer Products Inc. Composes pyrazole pour le traitement de maladies neurodegeneratives
BR0315157A (pt) 2002-10-09 2005-08-09 Rinat Neuroscience Corp Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
WO2004035577A2 (fr) 2002-10-16 2004-04-29 Gilead Sciences, Inc. Composes tricycliques pre-organises inhibiteurs d'integrase
US20040220186A1 (en) 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
JP2006527756A (ja) 2003-06-19 2006-12-07 ファイザー・プロダクツ・インク Ｎｋ１拮抗薬
WO2005020991A1 (fr) 2003-08-21 2005-03-10 Pfizer Products, Inc. Composes pour le traitement de maladies neurodegeneratives
US20070031416A1 (en) 2003-09-09 2007-02-08 Takeda Pharmaceutical Company Limited Use of antibody
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327319D0 (en) 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
CN1913778A (zh) 2004-01-28 2007-02-14 默克公司 趋化因子受体活性的氨基环戊基吡啶并吡嗪酮调节剂
CA2555071A1 (fr) 2004-02-02 2005-09-01 Pfizer Products Inc. Modulateurs du recepteur de l'histamine-3
CA2557785A1 (fr) 2004-03-09 2005-10-06 Merck & Co. Inc. Inhibiteurs de l'integrase du vih
PL1730119T3 (pl) 2004-03-23 2008-10-31 Pfizer Products Incorporated Związki imidazolowe do leczenia zaburzeń neurodegeneracyjnych
US20080076738A1 (en) 2004-04-14 2008-03-27 Cai Zhenhong R Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
US7456164B2 (en) 2004-05-07 2008-11-25 Pfizer, Inc 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
EP1595881A1 (fr) 2004-05-12 2005-11-16 Pfizer Limited Dérivés de tetrahydronaphthyridine en tant que ligands de récepteur H3 d'histamine
EP2298807A3 (fr) 2004-07-30 2011-05-18 Rinat Neuroscience Corp. Anticorps anti peptide amyloide beta, et leurs procedes d' utilisation
GB0423356D0 (en) 2004-10-21 2004-11-24 Merck Sharp & Dohme Therapeutic agents
FR2877015B1 (fr) 2004-10-21 2007-10-26 Commissariat Energie Atomique Revetement nanostructure et procede de revetement.
US20090074775A1 (en) 2004-12-22 2009-03-19 David Michael Holtzman Use Of Anti-AB Antibody To Treat Traumatic Brain Injury
UY29504A1 (es) 2005-04-29 2006-10-31 Rinat Neuroscience Corp Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
AU2006244424B2 (en) 2005-05-10 2011-09-22 Merck Sharp & Dohme Corp. HIV integrase inhibitors
US8227475B2 (en) 2005-05-12 2012-07-24 Pfizer Inc. Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
CA2608672A1 (fr) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridine [3,4-b] pyrazinones
WO2006126083A1 (fr) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Composes de pyridine [3 , 4-b] pyrazinones utilises comme inhibiteurs de pde-5
WO2006126081A2 (fr) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridine [2,3-b] pyrazinones
US7812040B2 (en) 2005-06-22 2010-10-12 Pfizer Inc. Histamine-3 receptor antagonists
US20070060534A1 (en) 2005-06-30 2007-03-15 Threshold Pharmaceuticals, Inc. Anthracycline analogs
US8158673B2 (en) 2005-10-27 2012-04-17 Pfizer Inc. Histamine-3 receptor antagonists
JP2009514846A (ja) 2005-11-04 2009-04-09 ファイザー・リミテッド テトラヒドロナフチリジン誘導体
EP1957465A4 (fr) 2005-11-18 2009-04-08 Glaxo Group Ltd Nouveaux intermédiaires et leur utilisation
JP2009515997A (ja) 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド グルコキナーゼ活性剤
KR20080069221A (ko) 2005-11-24 2008-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 모르폴린 타입의 신나미드 화합물
US20070117839A1 (en) 2005-11-24 2007-05-24 Eisai R&D Management Co., Ltd. Two cyclic cinnamide compound
WO2007063385A2 (fr) 2005-12-01 2007-06-07 Pfizer Products Inc. Antagonistes des recepteurs de l'histamine 3 pour des amines spirocycliques
WO2007069053A1 (fr) 2005-12-14 2007-06-21 Pfizer Products Inc. Antagonistes benzimidazoliques du récepteur h-3
AU2007207481B2 (en) 2006-01-20 2012-08-23 Merck Sharp & Dohme Corp. Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
WO2007088450A2 (fr) 2006-02-01 2007-08-09 Pfizer Products Inc. Chromane antagoniste du récepteur h-3
WO2007088462A1 (fr) 2006-02-01 2007-08-09 Pfizer Products Inc. Antagonistes du récepteur du h-3 à base de spirochromane
WO2007099423A1 (fr) 2006-03-02 2007-09-07 Pfizer Products Inc. Dérivés de 1-pyrrolidine indane en tant qu'antagonistes du récepteur d'histamine 3
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
JP2009539762A (ja) 2006-03-13 2009-11-19 ファイザー・プロダクツ・インク Ｈ３受容体のテトラリン拮抗薬
DK2013208T3 (da) 2006-04-21 2011-08-15 Pfizer Prod Inc Pyridin[3,4-B]pyrazinoner
AU2007254325B2 (en) 2006-05-15 2012-05-10 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2007136714A2 (fr) 2006-05-16 2007-11-29 Gilead Sciences, Inc. Inhibiteurs d'intégrase
CN101448793A (zh) 2006-05-19 2009-06-03 卫材R&D管理有限公司 脲型肉桂酰胺衍生物
WO2007138431A2 (fr) 2006-05-30 2007-12-06 Pfizer Products Inc. Antagonistes de l'éther histamine-3 azabicyclique
DK2124933T3 (da) 2007-01-22 2012-11-19 Pfizer Prod Inc Tosylatsalt af en terapeutisk forbindelse og farmaceutiske sammensætninger deraf
JP2010518064A (ja) 2007-02-12 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション Ａｄおよび関連状態の治療のためのピペラジン誘導体
AU2008216842A1 (en) 2007-02-12 2008-08-21 Merck Sharp & Dohme Corp. Piperidine derivatives
CL2008000582A1 (es) 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
WO2008137102A2 (fr) 2007-05-04 2008-11-13 Torreypines Therapeutics, Inc. Procédés de modulation de la bêta-amyloïde et composés utiles pour cette modulation
JP5209043B2 (ja) 2007-05-07 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション ガンマセクレターゼ調節剤
CA2686754C (fr) 2007-05-11 2014-10-28 F. Hoffmann-La Roche Ag Hetarylanilines en tant que modulateurs de l'amyloide beta
CL2008001540A1 (es) 2007-05-29 2009-05-22 Sgx Pharmaceuticals Inc Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
AU2008263206A1 (en) 2007-06-01 2008-12-18 Schering Corporation Gamma secretase modulators
RU2009148866A (ru) 2007-06-01 2011-07-20 Шеринг Корпорейшн (US) Модуляторы гамма-секретазы
EP2166854A4 (fr) 2007-06-13 2012-05-16 Merck Sharp & Dohme Dérivés du triazole destinés au traitement de la maladie d'alzheimer et d'états associés
JP2010532354A (ja) 2007-06-29 2010-10-07 シェーリング コーポレイション γセクレターゼモジュレーター
WO2009020580A1 (fr) 2007-08-06 2009-02-12 Schering Corporation Modulateurs de la gamma-sécrétase
TW200916469A (en) 2007-08-31 2009-04-16 Eisai R & Amp D Man Co Ltd Multi-cyclic compounds
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
WO2009032277A1 (fr) 2007-09-06 2009-03-12 Schering Corporation Modulateurs de la gamma sécrétase
MX2010003397A (es) 2007-09-28 2010-04-09 Schering Corp Moduladores de la gamma secretasa.
GB0720444D0 (en) 2007-10-18 2007-11-28 Glaxo Group Ltd Novel compounds
JP2011503002A (ja) 2007-11-05 2011-01-27 シェーリング コーポレイション γセクレターゼ調節剤
WO2009073779A1 (fr) * 2007-12-06 2009-06-11 Schering Corporation Modulateurs de la gamma sécrétase
US20100298372A1 (en) 2007-12-11 2010-11-25 Schering Corporation Gamma secretase modulators
WO2009076352A1 (fr) 2007-12-11 2009-06-18 Schering Corporation Modulateurs de gamma sécrétase
CN101896461A (zh) 2007-12-13 2010-11-24 安姆根有限公司 γ分泌酶调节剂
WO2009087127A1 (fr) 2008-01-11 2009-07-16 F. Hoffmann-La Roche Ag Modulateurs pour l'amyloïde-bêta
EP2257541B1 (fr) 2008-02-22 2013-08-14 F. Hoffmann-La Roche AG Modulateurs de la bêta-amyloïde
WO2009108766A1 (fr) 2008-02-29 2009-09-03 Schering Corporation Modulateurs de l’activité gamma-secrétase pour le traitement de la maladie d'alzheimer
US20100137320A1 (en) 2008-02-29 2010-06-03 Schering Corporation Gamma secretase modulators
BRPI0912539A2 (pt) 2008-05-05 2015-10-13 Amgen Inc composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
FR2933700B1 (fr) * 2008-07-08 2010-07-30 Sanofi Aventis Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
TW201006801A (en) 2008-07-18 2010-02-16 Lilly Co Eli Imidazole carboxamides
US8685972B2 (en) 2008-08-13 2014-04-01 Merck Sharp & Dohme Corp. Pyrimidine derivatives for treatment of alzheimer's disease
WO2010019392A1 (fr) 2008-08-13 2010-02-18 Merck Sharp & Dohme Corp. Dérivés de purine pour le traitement de la maladie d’alzheimer
EP2324009A1 (fr) 2008-08-27 2011-05-25 Eisai R&D Management Co., Ltd. Procédé de préparation de certains composés de cinnamide
CA2736924C (fr) 2008-10-09 2016-06-28 F. Hoffmann-La Roche Ag Modulateurs pour l'amyloide beta
WO2010054064A1 (fr) 2008-11-06 2010-05-14 Schering Corporation Modulateurs de sécrétase gamma
BRPI0921317A2 (pt) 2008-11-06 2017-06-06 Astrazeneca Ab composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
AU2009313527A1 (en) 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
JP5378532B2 (ja) 2008-11-10 2013-12-25 エフ．ホフマン−ラ ロシュ アーゲー 複素環γ−セクレターゼモジュレーター
WO2010071741A1 (fr) 2008-12-16 2010-06-24 Merck Sharp & Dohme Corp. Dérivés du triazole pour traitement de la maladie d'alzheimer
EP2379075A4 (fr) 2008-12-16 2012-05-30 Merck Sharp & Dohme Dérivés de triazole pour le traitement de la maladie d'alzheimer
PA8854101A1 (es) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
EP2379525B1 (fr) 2008-12-19 2015-07-29 Boehringer Ingelheim International GmbH Pyrimidine-4 carboxamides cycliques en tant qu'antagonistes du récepteur ccr2 pour le traitement d'inflammations, de l'asthme et des broncho-pneumopathies chroniques obstructives
WO2010075204A2 (fr) 2008-12-22 2010-07-01 Schering Corporation Modulateurs de gamma secrétase
CA2747744A1 (fr) 2008-12-22 2010-07-01 Theodros Asberom Modulateurs de gamma secretase
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
US8946426B2 (en) 2009-02-06 2015-02-03 Janssen Pharmaceuticals, Inc. Substituted bicyclic heterocyclic compounds as gamma secretase modulators
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
JP2012121809A (ja) 2009-02-26 2012-06-28 Eisai R & D Management Co Ltd 多環式化合物の製造法およびその中間体
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
JP2012051807A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd アリールイミダゾール化合物
AU2010218667A1 (en) 2009-02-26 2011-07-21 Eisai R&D Management Co., Ltd. Salt of tetrahydrotriazolopyridine derivative and crystal thereof
JP2012051805A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd テトラヒドロトリアゾロピリジン誘導体の製造方法
CA2751534A1 (fr) 2009-03-03 2010-09-10 Pfizer Inc. Nouveaux phenyl imidazoles et phenyl triazoles en tant que modulateurs de la gamma secretase
US8674109B2 (en) 2009-08-07 2014-03-18 Dow Agrosciences, Llc. Pesticidal compositions
US20120202787A1 (en) * 2009-10-20 2012-08-09 Pfizer Inc. Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
MX350761B (es) * 2009-12-22 2017-09-18 Vertex Pharma Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
CA2830027C (fr) 2011-03-31 2016-04-26 Pfizer Inc. Nouvelles pyridones bicycliques
US9181245B2 (en) 2012-05-16 2015-11-10 Janssen Pharmaceuticals, Inc. Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
TWI614238B (zh) 2012-09-21 2018-02-11 必治妥美雅史谷比公司 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
CA2889249C (fr) 2012-12-20 2021-02-16 Francois Paul Bischoff Derives tricycliques 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione utilises comme modulateurs de la gamma secretase
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
WO2015049616A1 (fr) 2013-10-04 2015-04-09 Pfizer Inc. Nouvelles pyridinones bicycliques utilisées comme modulateurs de gamma-sécrétase
US11497586B2 (en) 2014-03-21 2022-11-15 Align Technology, Inc. Segmented orthodontic appliance with elastics
EA031419B1 (ru) 2014-04-01 2018-12-28 Пфайзер Инк. ХРОМЕН И 1,1a,2,7b-ТЕТРАГИДРОЦИКЛОПРОПА[c]ХРОМЕН ПИРИДОПИРАЗИНДИОНЫ В КАЧЕСТВЕ МОДУЛЯТОРА ГАММА-СЕКРЕТАЗЫ

Also Published As

Publication number Publication date
ZA201501195B (en) 2016-01-27
DOP2015000069A (es) 2015-05-15
CN104662021A (zh) 2015-05-27
EP2897956B1 (fr) 2016-11-09
GEP201706659B (en) 2017-04-25
HK1206013A1 (zh) 2015-12-31
EP2897956A1 (fr) 2015-07-29
AU2013319845A1 (en) 2015-02-26
MD4583B1 (ro) 2018-07-31
ME02571B (me) 2017-06-20
PT2897956T (pt) 2017-01-13
GT201500069A (es) 2016-03-01
EA201590319A1 (ru) 2015-09-30
TWI500616B (zh) 2015-09-21
JP5844018B2 (ja) 2016-01-13
CY1118662T1 (el) 2017-07-12
NZ704863A (en) 2017-03-31
HUE031248T2 (en) 2017-06-28
US20140088111A1 (en) 2014-03-27
MX360599B (es) 2018-11-08
AR092628A1 (es) 2015-04-29
MA37886B1 (fr) 2016-09-30
EA026668B1 (ru) 2017-05-31
US9193726B2 (en) 2015-11-24
KR20150044948A (ko) 2015-04-27
MX2015003637A (es) 2015-06-05
HRP20161558T1 (hr) 2016-12-30
IL237163A (en) 2016-12-29
CU20150021A7 (es) 2015-08-27
PH12015500376B1 (en) 2015-04-20
UA110688C2 (uk) 2016-01-25
CA2882386C (fr) 2017-11-28
KR101725696B1 (ko) 2017-04-10
MD20150023A2 (ro) 2015-07-31
NI201500038A (es) 2015-06-05
CN104662021B (zh) 2016-08-24
TW201425311A (zh) 2014-07-01
SI2897956T1 (sl) 2017-02-28
LT2897956T (lt) 2017-01-10
US9751877B2 (en) 2017-09-05
JP2015529238A (ja) 2015-10-05
IL237163A0 (en) 2015-04-30
CL2015000717A1 (es) 2015-06-19
ECSP15015594A (es) 2017-08-31
MA37886A1 (fr) 2016-02-29
CA2882386A1 (fr) 2014-03-27
UY35039A (es) 2014-04-30
RS55426B1 (sr) 2017-04-28
AU2013319845B2 (en) 2017-09-14
AP2015008277A0 (en) 2015-02-28
MY181891A (en) 2021-01-12
DK2897956T3 (en) 2017-01-16
WO2014045156A1 (fr) 2014-03-27
SG11201501074WA (en) 2015-05-28
US20160024088A1 (en) 2016-01-28
US8916564B2 (en) 2014-12-23
US20150072990A1 (en) 2015-03-12
PH12015500376A1 (en) 2015-04-20
TN2015000084A1 (fr) 2016-06-29
PE20150686A1 (es) 2015-05-23
BR112015006436A2 (pt) 2017-07-04
ES2609987T3 (es) 2017-04-25
PL2897956T3 (pl) 2017-05-31
CR20150053A (es) 2015-03-25

Similar Documents

Publication Publication Date Title
IN2015DN01119A (fr)
IN2014MN02598A (fr)
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
IN2015DN01156A (fr)
PH12014501542A1 (en) Substituted pyrrolidine -2- carboxamides
IN2014DN09434A (fr)
IN2014DN09352A (fr)
IN2012DN03182A (fr)
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
IN2014DN09348A (fr)
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
MX2016006336A (es) Compuestos pirazolopirimidina.
MX343706B (es) Derivados heterocíclicos novedosos.
IN2014CN04530A (fr)
EA201390381A1 (ru) Триазиноксадиазолы
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
WO2014045162A8 (fr) Composés d'hexahydropyrano[3,4-d][1,3]thiazine-2-amine alkyl-substitués
MX2012013274A (es) Novedosos derivados de la pirimidina.
IN2015DN01151A (fr)
GB201209587D0 (en) Therapeutic compounds
IN2014DN09347A (fr)
WO2012135615A3 (fr) Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
MX340574B (es) Imidazo pirazinas.
IN2013DN02555A (fr)